Last updated: April 26, 2026
Cosmo Technologies Limited v. Lupin Ltd. (1:15-cv-00669): Litigation Summary and Patent-Strategy Takeaways
What is the case and where does it sit in the patent lifecycle?
Cosmo Technologies Limited (Cosmo) sued Lupin Ltd. (Lupin) in U.S. federal court in case 1:15-cv-00669, filed in 2015. The dispute is a classic Hatch-Waxman pathway case tied to ANDA litigation and use of U.S. patent rights by a branded pharmaceutical company against an ANDA filer.
The docket number identifies it as a district-court action in the U.S. District Court for the District of Delaware (as commonly assigned for this docket format and litigant set), but the record details that determine the substantive patent claims, asserted patents, and claim-construction outcomes are not present in the prompt provided here. Without docket text, complaint/answer, or an order history, a complete and accurate claim-by-claim litigation summary cannot be produced.
Which patents were at issue and how were they litigated?
A litigation summary that is useful for R&D or investment decisions needs at least the following, all of which are missing from the provided information:
- Asserted patent numbers (and their expiration dates)
- ANDA product and dosages (and whether it is paragraph IV vs paragraph III vs other procedural posture)
- Claim scope that Cosmo asserted (e.g., composition vs formulation vs method claims)
- Lupin’s defenses (invalidity grounds and non-infringement theories)
- Whether the court issued claim construction and the direction of that construction
- Whether there was a trial or stipulated judgment
- Whether the court issued a decision on infringement/validity or a settlement-triggered dismissal
Because those elements determine both legal risk and expected entry timing, an accurate narrative cannot be completed with only the case number and title fragment.
What is the procedural posture implied by “1:15-cv-00669”?
The “1:15-cv” format indicates a district-court civil action initiated in 2015. In Hatch-Waxman litigation, the key milestones typically include:
- Complaint filed with infringement allegations tied to an ANDA
- Initial pleadings and a schedule for claim construction and expert discovery
- Markman (claim construction) decision
- Motion practice (summary judgment on infringement/invalidity or narrowed issues)
- Trial or consent judgment following settlement
But the specific posture in this case, including whether the litigation ended by verdict or settlement, cannot be determined from the provided input alone.
What decision points drive valuation in ANDA patent cases like this?
For business professionals, the valuation impact usually depends on:
- Patent-by-patent strength: which asserted claims survive motions and how construed terms map to Lupin’s ANDA formulation/process
- Invalidity leverage: anticipation/obviousness success rate at the claim level, not the patent level
- Entry timing: whether any court injunction or stay preserves market exclusivity beyond initial statutory dates
- Settlement structure: whether there is a co-existence path, supply agreement, or reverse-payment-like terms (if present) and what triggers entry
Those items require actual docket/orders and settlement terms, which are not included.
What could be concluded from the limited information available?
Only the following can be stated without inventing facts:
- The case name is Cosmo Technologies Limited v. Lupin Ltd.
- The case is U.S. District Court action No. 1:15-cv-00669
- It is a patent litigation matter involving Cosmo and Lupin in the U.S.
A litigation summary that satisfies a “hard data” standard for patent analytics requires specific facts from the pleadings and orders. Those facts are not available in the prompt.
Key Takeaways
- Case identification is clear: Cosmo Technologies Limited v. Lupin Ltd., 1:15-cv-00669 (2015).
- Substantive litigation analysis is not possible from the provided input because the core proof elements (asserted patents, claims, claim construction, infringement/invalidity outcomes, and disposition) are not included.
FAQs
-
Is this an ANDA patent infringement case?
The case title and docket number align with Hatch-Waxman-style dispute patterns, but the specific ANDA linkage and paragraph posture are not provided in the prompt.
-
What patents did Cosmo assert against Lupin?
The asserted patent list is not included in the provided information.
-
Did the court construe key claim terms in Markman proceedings?
Claim construction orders are not included in the provided information.
-
How did the case end: verdict, summary judgment, or settlement?
The disposition and judgment history are not included in the provided information.
-
What does this mean for generic entry timing?
Entry timing depends on the actual ruling, any injunction, and settlement terms, none of which are included in the prompt.
References
[1] Cosmo Technologies Limited v. Lupin Ltd., 1:15-cv-00669 (U.S. District Court).
